Males suffering from issues such as breast enlargement are recommended to undergo male breast surgery in Jaipur. In medical terminology, the surgery to reduce excess male breast is termed as gynaecomastia. Obesity and hormonal dysfunction can be the prime cause of breast enlargement in males. At Rejuvena Cosmo Care, we have a team of surgeons that has expertise in treating a wide variety of conditions associated with excess breasts in males such as the bulging chest, puffy nipples, chest fat deposit, along with chest lump. Moreover, we are the preferred choice among individuals who do not want to take any risk with their looks and thus, we provide reliable and quality cosmetic solutions.
Global Male Breast Cancer Research Report: By Type (Infiltrating Ductal Carcinoma, Inflammatory Breast Cancer, Paget Disease, Ductal Carcinoma), by Diagnosis (Mammography, Biopsy, Pet Scan, Others), by Treatment (Local, Systemic) – Forecast Till 2027Male Breast Cancer refers to the extra growth of breast tissues.
Some of the numerous factors that are causing this cancerous growth include obesity, growing age.
According to the current clinical practice standards, specific treatments are gender-neutral in their indication, but some medicines have been approved only for men.The male breast cancer market is already equipped with various effective treatments such as hormone therapy which is also called endocrine therapy or chemotherapy.
The rising prevalence of the male breast cancer and the availability of effective therapeutics are two the key driving forces behind the market for breast cancer in men.The male breast cancer market is growing slowly but steadily.
The increasing governmental initiatives in terms of funding are encouraging pharmaceutical companies to develop more effective treatment procedures.The unavailability of comprehensive treatment presages the broad scope for the market to evolve further.
Hence, pharma companies are investing increasingly in R that can bring about breakthrough drug discoveries.Conversely, high costs associated with the clinical trials, prolonged approvals, adverse effects of therapies or drugs are restricting the market growth.
